Published in Vaccine Weekly, July 7th, 1997
Dendritic cells are a type of immune system cell that plays a key role in initiating an immune response to cancer and infectious diseases.
The study data, presented at the 13th European Immunology Meeting, held in Amsterdam, The Netherlands, during June 1997, showed an average 30-fold increase in functionally mature dendritic cells (DC) in the peripheral blood of subjects treated with Flt3 ligand. The increase in DC was detected as early as day 5 of treatment, peaking by day 9 to an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1997-07-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.